laboratory for targeted drug delivery & personalized medicine technologies 

ABOUT US

Our research group is aimed at improving patients’ quality of life and bettering their treatment by developing innovative medical technologies. Specifically, we focus on targeting metastatic cancer with nanotechnology, and on constructing miniature medical devices that couple diagnosis to therapy (theranostic devices). Our lab is headed by Dr Avi Schroeder, who has years of experience in nanotechnology and personalized medicine.

Dr. Avi Schroeder has translational experience with the development of liposome-based clinical systems.  He is the author of scientific papers in the field of nanotechnology and medicine. Schroeder is the inventor on 14 patents, and recipient of 20 national and international innovation awards. Dr. Schroeder is a scientific-entrepreneur, starting 5 successful Technion spin-outs.

Our research is supported by:

Phospholipids Research Center

H2020-ERC grant

ERC-STG-2015-680242

 

 Israel Innovation Authority

 

 Israel Science Foundation - ISF

Years of Experience

Billion Liposomes

Countries Visited

Staff Children

Show More
 
 
Our Address

Department of Chemical Engineering,

Technion – Israel Institute of Technology

Rooms: 351 (office); 102 (lab)
Haifa 32000, ISRAEL

Dr Avi Schroeder: avids@technion.ac.il 

Tel (Avi): +972-77-887-1953 // (lab) +972-77-887-1862

Lilach Koren

Lilach received her B.Sc in molecular biochemistry from the Technion (2010). She completed her PhD studies under the supervision of Prof. Ami Aronheim at the Technion Faculty of Medicine. In her thesis she studied the mechanism in which transcription factor ATF3 impacts cardiac hypertrophy. Lilach joined the Schroeder lab in 2018 and is involved in a variety of projects.